Trending stocks

CIBT Education Group Inc Debt jumped on 1,550% in 2015 and EBITDA jumped on 431%

02.12.2015 • About CIBT Education Group Inc ($MBA) • By InTwits

CIBT Education Group Inc reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • CIBT Education Group Inc is a company in decline: FY2015 revenue growth was -13.7%, 5 years revenue CAGR was -13.0%
  • EBITDA Margin is quite volatile: 3.4% in FY2015, -0.9% in FY2014, 0.0% in FY2013, 2.4% in FY2012, -1.8% in FY2011
  • CIBT Education Group Inc has low CAPEX intensity: 5 year average CAPEX/Revenue was 2.7%. At the same time it's a lot of higher than industry average of 8.0%.
  • CAPEX is quite volatile: 0.57 in FY2015, 0.38 in FY2014, 1.3 in FY2013, 1.6 in FY2012, 0.49 in FY2011
  • The company has unprofitable business model: ROIC is at -0.7%
  • It operates with high leverage: Net Debt/EBITDA is 18.4x while industry average is 6.0x
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

CIBT Education Group Inc ($MBA) key annual financial indicators

mln. $201120122013201420152015/2014
P&L
Revenue58.57533.72430.43130.91626.686-13.7%
Gross Profit29.31318.61616.72018.10016.697-7.8%
SG&A16.035
EBITDA-1.0470.8210.003-0.2750.908-430.5%
Net Income-9.814-1.172-1.8855.1250.863-83.2%
Balance Sheet
Cash6.4578.0753.3772.7061.731-36.0%
Short Term Debt2.2541.7452.9200.60818.0772,873.4%
Long Term Debt0.2830.6150.4560.5090.346-32.0%
Cash flow
Capex0.4881.6041.3400.3770.56750.2%
Ratios
Revenue growth9.3%-42.4%-9.8%1.6%-13.7%
EBITDA growth-134.7%-178.4%-99.6%-8,747.4%-430.5%
Gross Margin50.0%55.2%54.9%58.5%62.6%4.0%
EBITDA Margin-1.8%2.4%0.0%-0.9%3.4%4.3%
Net Income Margin-16.8%-3.5%-6.2%16.6%3.2%-13.3%
SG&A, % of revenue60.1%60.1%
CAPEX, % of revenue0.8%4.8%4.4%1.2%2.1%0.9%
ROIC-13.3%-8.5%-15.5%-10.6%-0.7%9.9%
ROE-46.2%-7.3%-13.0%32.8%5.1%-27.7%
Net Debt/EBITDA-7.0x-0.3x18.4x18.4x

Revenue and profitability


CIBT Education Group Inc's Revenue dropped on 13.7% in FY2015. Revenue decline happened at the same time with EBITDA margin expansion. EBITDA Margin increased on 4.3 pp from -0.89% to 3.4% in FY2015.

Gross Margin increased on 4.0 pp from 58.5% to 62.6% in FY2015.

Net Income marign dropped on 13.3 pp from 16.6% to 3.2% in FY2015.

Capital expenditures (CAPEX) and working capital investments


In FY2015 CIBT Education Group Inc had CAPEX/Revenue of 2.1%. CAPEX/Revenue decreased on 2.6 pp from 4.8% in FY2012 to 2.1% in FY2015. For the last three years the average CAPEX/Revenue was 2.6%.Battling declining revenue CIBT Education Group Inc invested a large share of EBITDA (62.4%) to CAPEX but that didn't help at least in this year.

Return on investment


The company operates at negative ROIC (-0.68%) and low but positive ROE (5.12%). ROIC increased on 9.9 pp from -10.6% to -0.68% in FY2015. ROE dropped on 27.7 pp from 32.8% to 5.1% in FY2015.

Leverage (Debt)


Debt level is 18.4x Net Debt / EBITDA and 20.3x Debt / EBITDA. Net Debt / EBITDA surged18.4x from to 18.4x in FY2015. Debt jumped on 1,550% in FY2015 while cash dropped on 36.0% in FY2015.

Appendix 1: Peers in Consumer, Non-cyclical


Below we provide CIBT Education Group Inc benchmarking against other companies in Consumer, Non-cyclical industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)43.8%-38.8%-72.9%218,969.1%
Cardiome Pharma Corp ($COM)-97.7%-47.6%471.7%566.0%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
Concordia Healthcare Corp ($CXR)159.5%
 
Median (85 companies)12.3%8.7%6.9%13.2%6.3%
CIBT Education Group Inc ($MBA)-42.4%-9.8%1.6%-13.7%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (73 companies)33.7%35.8%35.5%34.6%26.2%
CIBT Education Group Inc ($MBA)50.0%55.2%54.9%58.5%62.6%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (84 companies)8.2%8.5%9.0%10.8%7.0%
CIBT Education Group Inc ($MBA)-1.8%2.4%0.0%-0.9%3.4%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%63.4%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%
 
Median (85 companies)2.4%2.6%2.4%2.6%2.9%
CIBT Education Group Inc ($MBA)0.8%4.8%4.4%1.2%2.1%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (85 companies)8.0%7.2%6.7%7.8%8.0%
CIBT Education Group Inc ($MBA)-13.3%-8.5%-15.5%-10.6%-0.7%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x12.3x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x
 
Median (70 companies)1.8x2.8x2.2x2.7x1.5x